FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:1410-1411 April 3, 2003 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Leape, L. L. PubMed Citation

To the Editor: In his article about the reporting of adverse events (Nov. 14 issue),¹ Leape describes two reporting systems that focus on complications from medications: the Medication Error Reporting Program and the MedMARx program, which together receive 7000 reports annually.

Readers should be aware of another reporting system for adverse events and medical errors. The Toxic Exposure Surveillance System (TESS), sponsored by the American Association of Poison Control Centers, receives reports from 64 poison centers (serving 98.9 percent of the U.S. population).² Of 2,267,979 reports filed in 2001 in TESS, 167,014 (7.4 percent) were therapeutic errors, and 35,646 (1.6 . . . [Full Text of this Article]

This article has been cited by other articles:

• Vassilev, Z. P., Chu, A. F., Ruck, B., Adams, E. H., Marcus, S. M. (2009). Evaluation of adverse drug reactions reported to a poison control center between 2000 and 2007. Am J Health Syst Pharm 66: 481-487 [Abstract] [Full Text]  
• Ruck, B., Marcus, S., Kashani, J., Vassilev, Z. (2006). Drug Safety Monitoring. JAMA 296: 1590-1590 [Full Text]